KRAS and pancreatic neoplasm: Likewise, digital droplet PCR has been used to measure EV-related KRAS mutant allele frequency (MAF) in NACT-treated pancreatic cancer, evidencing a decrease in KRAS MAF in responsive patients with no disease progression [143].